{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T15:14:56Z","timestamp":1790522096717,"version":"4.1.0"},"reference-count":99,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP-106494"],"award-info":[{"award-number":["MOP-106494"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Canada Research Chair program"},{"DOI":"10.13039\/100012013","name":"Quebec Network of Oral and Bone Health Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012013","id-type":"DOI","asserted-by":"crossref"}]},{"name":"German Studienstiftung des deutschen Volkes"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mutation Research\/Reviews in Mutation Research"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.mrrev.2015.04.002","type":"journal-article","created":{"date-parts":[[2015,5,5]],"date-time":"2015-05-05T12:36:07Z","timestamp":1430829367000},"page":"7-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Engineered mutations in fibrillin-1 leading to Marfan syndrome act at the protein, cellular and organismal levels"],"prefix":"10.1016","volume":"765","author":[{"given":"Karina A.","family":"Zeyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6535-9872","authenticated-orcid":false,"given":"Dieter P.","family":"Reinhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mrrev.2015.04.002_bib0500","series-title":"Connective Tissue and its Heritable Disorders","first-page":"585","article-title":"Marfan syndrome and other microfibrillar disorders","author":"Pyeritz","year":"2002"},{"key":"10.1016\/j.mrrev.2015.04.002_bib0505","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1056\/NEJM199010043231402","article-title":"Location on chromosome 15 of the gene defect causing Marfan syndrome","volume":"323","author":"Kainulainen","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0510","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/352337a0","article-title":"Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene","volume":"352","author":"Dietz","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.mrrev.2015.04.002_bib0515","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/humu.10249","article-title":"Update of the UMD-FBN1 mutation database and creation of an FBN1 polymorphism database","volume":"22","author":"Collod-Beroud","year":"2003","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0520","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1083\/jcb.103.6.2499","article-title":"Fibrillin, a new 350-kD glycoprotein, is a component of extracellular microfibrils","volume":"103","author":"Sakai","year":"1986","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0525","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1083\/jcb.129.4.1165","article-title":"Developmental expression of fibrillin genes suggests heterogeneity of extracellular microfibrils","volume":"129","author":"Zhang","year":"1995","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0530","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.ygeno.2003.08.023","article-title":"Differential expression of fibrillin-3 adds to microfibril variety in human and avian, but not rodent, connective tissues","volume":"83","author":"Corson","year":"2004","journal-title":"Genomics"},{"key":"10.1016\/j.mrrev.2015.04.002_bib0535","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.matbio.2010.10.003","article-title":"Fibrillin-3 expression in human development","volume":"30","author":"Sabatier","year":"2011","journal-title":"Matrix Biol."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0540","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/hmg\/2.7.961","article-title":"Genomic organization of the sequence coding for fibrillin, the defective gene product in Marfan syndrome","volume":"2","author":"Pereira","year":"1993","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0545","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1002\/j.1460-2075.1988.tb03045.x","article-title":"The role of \u03b2-hydroxyaspartate and adjacent carboxylate residues in the first EGF domain of human factor IX","volume":"7","author":"Rees","year":"1988","journal-title":"EMBO J."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0550","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/351164a0","article-title":"Key residues involved in calcium-binding motifs in EGF-like domains","volume":"351","author":"Handford","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.mrrev.2015.04.002_bib0555","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/protein\/5.6.489","article-title":"Ligand requirements for Ca2+ binding to EGF-like domains","volume":"5","author":"Mayhew","year":"1992","journal-title":"Protein Eng."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0560","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0092-8674(00)81259-3","article-title":"Solution structure of a pair of calcium-binding epidermal growth factor-like domains: implications for the Marfan syndrome and other genetic disorders","volume":"85","author":"Downing","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.mrrev.2015.04.002_bib0565","doi-asserted-by":"crossref","first-page":"7368","DOI":"10.1074\/jbc.272.11.7368","article-title":"Calcium determines the shape of fibrillin","volume":"272","author":"Reinhardt","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0570","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1006\/jmbi.1999.3513","article-title":"Backbone dynamics of a cbEGF domain pair in the presence of calcium","volume":"296","author":"Werner","year":"2000","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0575","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1074\/jbc.272.2.1231","article-title":"Calcium stabilizes fibrillin-1 against proteolytic degradation","volume":"272","author":"Reinhardt","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0580","doi-asserted-by":"crossref","first-page":"19489","DOI":"10.1074\/jbc.271.32.19489","article-title":"Fibrillin-1 and fibulin-2 interact and are colocalized in some tissues","volume":"271","author":"Reinhardt","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0585","doi-asserted-by":"crossref","first-page":"36035","DOI":"10.1074\/jbc.M104985200","article-title":"Interactions of fibrillin-1 with heparin\/heparan sulfate: implications for microfibrillar assembly","volume":"276","author":"Tiedemann","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0590","doi-asserted-by":"crossref","first-page":"50795","DOI":"10.1074\/jbc.M210611200","article-title":"Homo- and heterotypic fibrillin-1 and -2 interactions constitute the basis for the assembly of microfibrils","volume":"277","author":"Lin","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0595","doi-asserted-by":"crossref","first-page":"23748","DOI":"10.1074\/jbc.M400212200","article-title":"Molecular basis of elastic fiber formation. Critical interactions and a tropoelastin-fibrillin-1 cross-link","volume":"279","author":"Rock","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0600","doi-asserted-by":"crossref","first-page":"5013","DOI":"10.1074\/jbc.M409029200","article-title":"Homotypic fibrillin-1 interactions in microfibril assembly","volume":"280","author":"Marson","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0605","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.str.2004.02.023","article-title":"Structure of the integrin binding fragment from fibrillin-1 gives new insights into microfibril organization","volume":"12","author":"Lee","year":"2004","journal-title":"Structure"},{"key":"10.1016\/j.mrrev.2015.04.002_bib0610","doi-asserted-by":"crossref","first-page":"14076","DOI":"10.1074\/jbc.M412832200","article-title":"Ca2+-dependent interface formation in fibrillin-1","volume":"280","author":"Jensen","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0615","doi-asserted-by":"crossref","first-page":"12199","DOI":"10.1074\/jbc.M208266200","article-title":"Solution structure and dynamics of a calcium binding epidermal growth factor-like domain pair from the neonatal region of human fibrillin-1","volume":"278","author":"Smallridge","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0620","doi-asserted-by":"crossref","first-page":"6659","DOI":"10.1093\/emboj\/16.22.6659","article-title":"Solution structure of the transforming growth factor \u00df-binding protein-like module, a domain associated with matrix fibrils","volume":"16","author":"Yuan","year":"1997","journal-title":"EMBO J."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0625","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1006\/geno.1993.1350","article-title":"Fibrillin binds calcium and is coded by cDNAs that reveal a multidomain structure and alternatively spliced exons at the 5\u2019 end","volume":"17","author":"Corson","year":"1993","journal-title":"Genomics"},{"key":"10.1016\/j.mrrev.2015.04.002_bib0630","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.str.2009.03.014","article-title":"Structure and interdomain interactions of a hybrid domain: a disulphide-rich module of the fibrillin\/LTBP superfamily of matrix proteins","volume":"17","author":"Jensen","year":"2009","journal-title":"Structure"},{"key":"10.1016\/j.mrrev.2015.04.002_bib0635","first-page":"S2","article-title":"Structure of the glomerular mesangium: a biomechanical interpretation","volume":"30","author":"Kriz","year":"1990","journal-title":"Kidney Int. Suppl."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0640","first-page":"851","article-title":"The fine structure of the ciliary zonule and ciliary epithelium","volume":"10","author":"Raviola","year":"1971","journal-title":"Invest. Ophthalmol."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0645","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/bdrc.20111","article-title":"New insights into elastic fiber assembly","volume":"81","author":"Wagenseil","year":"2007","journal-title":"Birth Defects Res. C. Embryo Today"},{"key":"10.1016\/j.mrrev.2015.04.002_bib0650","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/ng1116","article-title":"Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome","volume":"33","author":"Neptune","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0655","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1126\/science.1124287","article-title":"Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome","volume":"312","author":"Habashi","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.mrrev.2015.04.002_bib0660","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ahj.2007.06.024","article-title":"Rationale and design of a randomized clinical trial of beta-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome","volume":"154","author":"Lacro","year":"2007","journal-title":"Am. Heart J."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0665","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.acvd.2010.04.008","article-title":"Rationale and design of a randomized clinical trial (Marfan Sartan) of angiotensin II receptor blocker therapy versus placebo in individuals with Marfan syndrome","volume":"103","author":"Detaint","year":"2010","journal-title":"Arch. Cardiovasc. Dis."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0670","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1056\/NEJMoa1404731","article-title":"Atenolol versus losartan in children and young adults with Marfan's syndrome","volume":"371","author":"Lacro","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0675","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1056\/NEJM199405123301902","article-title":"Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan's syndrome","volume":"330","author":"Shores","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0680","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/ng0194-64","article-title":"Mutations in the fibrillin gene responsible for dominant ectopia lentis and neonatal Marfan syndrome","volume":"6","author":"Kainulainen","year":"1994","journal-title":"Nat. Genet."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0685","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1002\/ajmg.a.33690","article-title":"Marfan syndrome with neonatal progeroid syndrome-like lipodystrophy associated with a novel frameshift mutation at the 3\u2019 terminus of the FBN1-gene","volume":"152A","author":"Graul-Neumann","year":"2010","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.mrrev.2015.04.002_bib0690","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/jmg.40.1.34","article-title":"In frame fibrillin-1 gene deletion in autosomal dominant Weill-Marchesani syndrome","volume":"40","author":"Faivre","year":"2003","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0695","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ajhg.2011.05.012","article-title":"Mutations in the TGF\u03b2 binding-protein-like domain 5 of FBN1 are responsible for acromicric and geleophysic dysplasias","volume":"89","author":"Le Goff","year":"2011","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0700","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJM199204023261401","article-title":"Genetic linkage of the Marfan syndrome, ectopia lentis, and congenital contractural arachnodactyly to the fibrillin genes on chromosomes 15 and 5. The International Marfan Syndrome Collaborative Study","volume":"326","author":"Tsipouras","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0705","doi-asserted-by":"crossref","first-page":"23ra20","DOI":"10.1126\/scitranslmed.3000488","article-title":"Mutations in fibrillin-1 cause congenital scleroderma: stiff skin syndrome","volume":"2","author":"Loeys","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0710","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1086\/520125","article-title":"Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: An international study","volume":"81","author":"Faivre","year":"2007","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0715","doi-asserted-by":"crossref","first-page":"32810","DOI":"10.1074\/jbc.M111.221804","article-title":"Classical and neonatal Marfan syndrome mutations in fibrillin-1 cause differential protease susceptibilities and protein function","volume":"286","author":"Kirschner","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0720","doi-asserted-by":"crossref","first-page":"31854","DOI":"10.1016\/S0021-9258(19)84100-5","article-title":"Marfan syndrome-causing mutations in fibrillin-1 result in gross morphological alterations and highlight the structural importance of the second hybrid domain","volume":"281","author":"Mellody","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0725","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1006\/jmbi.1997.1593","article-title":"Metal ion dependency of microfibrils supports a rod-like conformation for fibrillin-1 calcium-binding epidermal growth factor-like domains","volume":"276","author":"Cardy","year":"1998","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0730","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1006\/jmbi.1996.0003","article-title":"Calcium binding properties of an epidermal growth factor-like domain pair from human fibrillin-1","volume":"255","author":"Knott","year":"1996","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0735","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1006\/jmbi.1996.0237","article-title":"Fibrillin 1: organization in microfibrils and structural properties","volume":"258","author":"Reinhardt","year":"1996","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0740","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1021\/bm5000696","article-title":"Early fibrillin-1 assembly monitored through a modifiable recombinant cell approach","volume":"15","author":"Hubmacher","year":"2014","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.mrrev.2015.04.002_bib0745","doi-asserted-by":"crossref","first-page":"10155","DOI":"10.1073\/pnas.1401697111","article-title":"C-terminal propeptide is required for fibrillin-1 secretion and blocks premature assembly through linkage to domains cbEGF41-43","volume":"111","author":"Jensen","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0750","doi-asserted-by":"crossref","first-page":"51258","DOI":"10.1074\/jbc.M408156200","article-title":"Structural consequences of cysteine substitutions C1977Y and C1977R in calcium-binding epidermal growth factor-like domain 30 of human fibrillin-1","volume":"279","author":"Suk","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0755","doi-asserted-by":"crossref","first-page":"7807","DOI":"10.1074\/jbc.273.14.7807","article-title":"A Gly --> Ser change causes defective folding in vitro of calcium-binding epidermal growth factor-like domains from Factor IX and Fibrillin-1","volume":"273","author":"Whiteman","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0760","doi-asserted-by":"crossref","first-page":"17156","DOI":"10.1074\/jbc.M006547200","article-title":"A G1127S change in calcium-binding epidermal growth factor-like domain 13 of human fibrillin-1 causes short range conformational effects","volume":"276","author":"Whiteman","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0765","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1006\/jmbi.1998.2368","article-title":"Defective calcium binding to Fibrillin-1: consequence of an N2144S change for Fibrillin-1 structure and function","volume":"285","author":"Kettle","year":"1999","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0770","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1093\/hmg\/ddm035","article-title":"Cellular and molecular studies of Marfan syndrome mutations identify co-operative protein folding in the cbEGF12-13 region of fibrillin-1","volume":"16","author":"Whiteman","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0775","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/1074-5521(95)90281-3","article-title":"Fibrillin domain folding and calcium binding: significance to Marfan syndrome","volume":"2","author":"Wu","year":"1995","journal-title":"Chem. Biol."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0780","doi-asserted-by":"crossref","first-page":"32924","DOI":"10.1074\/jbc.M405239200","article-title":"Consequences of cysteine mutations in calcium-binding epidermal growth factor modules of fibrillin-1","volume":"279","author":"Vollbrandt","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0785","doi-asserted-by":"crossref","first-page":"12339","DOI":"10.1074\/jbc.275.16.12339","article-title":"Mutations in calcium-binding epidermal growth factor modules render fibrillin-1 susceptible to proteolysis: a potential disease-causing mechanism in Marfan syndrome","volume":"275","author":"Reinhardt","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0790","doi-asserted-by":"crossref","first-page":"6751","DOI":"10.1074\/jbc.270.12.6751","article-title":"The calcium binding properties and molecular organization of epidermal growth factor-like domains in human fibrillin-1","volume":"270","author":"Handford","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0795","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s004390000368","article-title":"Differential effect of FBN1 mutations on in vitro proteolysis of recombinant fibrillin-1 fragments","volume":"107","author":"Booms","year":"2000","journal-title":"Hum. Genet."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0800","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/hmg\/ddg081","article-title":"Defective secretion of recombinant fragments of fibrillin-1: implications of protein misfolding for the pathogenesis of Marfan syndrome and related disorders","volume":"12","author":"Whiteman","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0805","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1093\/hmg\/2.12.2135","article-title":"Missense mutations impair intracellular processing of fibrillin and microfibril assembly in Marfan syndrome","volume":"2","author":"Aoyama","year":"1993","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0810","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1086\/302582","article-title":"Cysteine substitutions in epidermal growth Factor-like domains of Fibrillin-1: distinct effects on biochemical and clinical phenotypes","volume":"65","author":"Schrijver","year":"1999","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0815","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1172\/JCI200420641","article-title":"Evidence for a critical contribution of haploinsufficiency in the complex pathogenesis of Marfan syndrome","volume":"114","author":"Judge","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0820","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/hmg\/3.2.373","article-title":"Two novel mutations and a neutral polymorphism in EGF-like domains of the fibrillin gene (FBN1): SSCP screening of exons 15-21 in Marfan syndrome patients","volume":"3","author":"Hayward","year":"1994","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0825","first-page":"8","article-title":"Fifteen novel FBN1 mutations causing Marfan syndrome detected by heteroduplex analysis of genomic amplicons","volume":"57","author":"Nijbroek","year":"1995","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0830","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1001\/archinte.161.20.2447","article-title":"Genotype and phenotype analysis of 171 patients referred for molecular study of the fibrillin-1 gene FBN1 because of suspected Marfan syndrome","volume":"161","author":"Loeys","year":"2001","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0835","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/jmg.39.8.589","article-title":"Twelve novel FBN1 mutations in Marfan syndrome and Marfan related phenotypes test the feasibility of FBN1 mutation testing in clinical practice","volume":"39","author":"Halliday","year":"2002","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0840","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1046\/j.1440-1754.1999.00355.x","article-title":"Neonatal Marfan syndrome: a case report","volume":"35","author":"Ng","year":"1999","journal-title":"J. Paediatr. Child Health"},{"key":"10.1016\/j.mrrev.2015.04.002_bib0845","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/(SICI)1098-1004(1999)13:1<84::AID-HUMU15>3.0.CO;2-U","article-title":"Identification of 8 new mutations in Brazilian families with Marfan syndrome","volume":"13","author":"Perez","year":"1999","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0850","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/ejhg.2008.207","article-title":"Clinical and mutation-type analysis from an international series of 198 probands with a pathogenic FBN1 exons 24-32 mutation","volume":"17","author":"Faivre","year":"2009","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0855","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1093\/hmg\/2.11.1813","article-title":"Mutation screening of complete fibrillin-1 coding sequence: report of five new mutations, including two in 8-cysteine domains","volume":"2","author":"Tynan","year":"1993","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0860","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/(SICI)1098-1004(1999)14:2<181::AID-HUMU10>3.0.CO;2-6","article-title":"Identification of 9 novel FBN1 mutations in German patients with Marfan syndrome","volume":"14","author":"El Aleem","year":"1999","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0865","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0955-0674(00)00233-7","article-title":"ER quality control: towards an understanding at the molecular level","volume":"13","author":"Ellgaard","year":"2001","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0870","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0092-8674(95)90059-4","article-title":"The structure of a Ca2+-binding epidermal growth factor-like domain: its role in protein-protein interactions","volume":"82","author":"Rao","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.mrrev.2015.04.002_bib0875","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1006\/geno.1993.1349","article-title":"Four novel FBN1 mutations: significance for mutant transcript level and EGF-like domain calcium binding in the pathogenesis of Marfan syndrome","volume":"17","author":"Dietz","year":"1993","journal-title":"Genomics"},{"key":"10.1016\/j.mrrev.2015.04.002_bib0880","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/sj.ejhg.5200582","article-title":"Classic, atypically severe and neonatal Marfan syndrome: twelve mutations and genotype-phenotype correlations in FBN1 exons 24-40","volume":"9","author":"Tiecke","year":"2001","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0885","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1089\/gte.1997.1.237","article-title":"Denaturing HPLC-identified novel FBN1 mutations, polymorphisms, and sequence variants in Marfan syndrome and related connective tissue disorders","volume":"1","author":"Liu","year":"1997","journal-title":"Genet. Test."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0890","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/hmg\/2.4.475","article-title":"A novel fibrillin mutation in the Marfan syndrome which could disrupt calcium binding of the epidermal growth factor-like module","volume":"2","author":"Hewett","year":"1993","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0895","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/(SICI)1096-8628(19960329)62:3<233::AID-AJMG7>3.0.CO;2-U","article-title":"Delineation of the Marfan phenotype associated with mutations in exons 23-32 of the FBN1 gene","volume":"62","author":"Putnam","year":"1996","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0900","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/(SICI)1098-1004(1997)9:4<359::AID-HUMU10>3.0.CO;2-1","article-title":"Three novel fibrillin mutations in exons 25 and 27: classic versus neonatal Marfan syndrome","volume":"9","author":"Wang","year":"1997","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0905","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1093\/hmg\/9.13.1987","article-title":"Molecular effects of calcium binding mutations in Marfan syndrome depend on domain context","volume":"9","author":"McGettrick","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0910","first-page":"1287","article-title":"A Gly1127Ser mutation in an EGF-like domain of the fibrillin-1 gene is a risk factor for ascending aortic aneurysm and dissection","volume":"56","author":"Francke","year":"1995","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0915","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/humu.20239","article-title":"Identification of 29 novel and nine recurrent fibrillin-1 (FBN1) mutations and genotype-phenotype correlations in 76 patients with Marfan syndrome","volume":"26","author":"Rommel","year":"2005","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0920","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/humu.10112","article-title":"TGGE screening of the entire FBN1 coding sequence in 126 individuals with marfan syndrome and related fibrillinopathies","volume":"20","author":"Katzke","year":"2002","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0925","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1042\/bj3400171","article-title":"Fibrillin degradation by matrix metalloproteinases: implications for connective tissue remodelling","volume":"340","author":"Ashworth","year":"1999","journal-title":"Biochem. J."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0930","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0014-5793(96)00325-0","article-title":"Cell adhesion and integrin binding to recombinant human fibrillin-1","volume":"384","author":"Pfaff","year":"1996","journal-title":"FEBS Lett."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0935","doi-asserted-by":"crossref","first-page":"34605","DOI":"10.1074\/jbc.M303159200","article-title":"Cell adhesion to fibrillin-1 molecules and microfibrils is mediated by alpha5 beta1 and alphav beta3 integrins","volume":"278","author":"Bax","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0940","first-page":"6743","article-title":"\u03b1V\u00df6 is a novel receptor for human fibrillin-1: Comparative studies of molecular determinants underlying integrin-RGD affinity and specificity","volume":"282","author":"Jovanovic","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0945","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1242\/jcs.003954","article-title":"Cell adhesion to fibrillin-1: identification of an Arg-Gly-Asp-dependent synergy region and a heparin-binding site that regulates focal adhesion formation","volume":"120","author":"Bax","year":"2007","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0950","doi-asserted-by":"crossref","first-page":"30526","DOI":"10.1074\/jbc.M501390200","article-title":"Fibrillin-1 interactions with heparin: implications for microfibril and elastic fibre assembly","volume":"280","author":"Cain","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0955","doi-asserted-by":"crossref","first-page":"e48634","DOI":"10.1371\/journal.pone.0048634","article-title":"Fibrillin-1 mutations causing Weill-Marchesani syndrome and acromicric and geleophysic dysplasias disrupt heparan sulfate interactions","volume":"7","author":"Cain","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.mrrev.2015.04.002_bib0960","series-title":"Biology of Extracellular Matrix","first-page":"233","article-title":"Microfibrils and fibrillin","author":"Hubmacher","year":"2011"},{"key":"10.1016\/j.mrrev.2015.04.002_bib0965","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0070-2153(06)75004-9","article-title":"Fibrillins From biogenesis of microfibrils to signaling functions","volume":"75","author":"Hubmacher","year":"2006","journal-title":"Curr. Top. Dev. Biol."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0970","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1161\/CIRCRESAHA.107.157776","article-title":"Loss of elastic fiber integrity and reduction of vascular smooth muscle contraction resulting from the upregulated activities of matrix metalloproteinase-2 and -9 in the thoracic aortic aneurysm in Marfan syndrome","volume":"101","author":"Chung","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0975","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1161\/CIRCRESAHA.111.253740","article-title":"miR-29b participates in early aneurysm development in Marfan syndrome","volume":"110","author":"Merk","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0980","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1161\/ATVBAHA.114.304364","article-title":"Enhanced caspase activity contributes to aortic wall remodeling and early aneurysm development in a Murine model of Marfan syndrome","volume":"35","author":"Emrich","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.mrrev.2015.04.002_bib0985","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1161\/CIRCULATIONAHA.108.841981","article-title":"Circulating transforming growth factor-beta in Marfan syndrome","volume":"120","author":"Matt","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.mrrev.2015.04.002_bib0990","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1126\/science.1192149","article-title":"Noncanonical TGFbeta signaling contributes to aortic aneurysm progression in Marfan syndrome mice","volume":"332","author":"Holm","year":"2011","journal-title":"Science"}],"container-title":["Mutation Research\/Reviews in Mutation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383574215000265?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383574215000265?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T10:16:39Z","timestamp":1761300999000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1383574215000265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":99,"alternative-id":["S1383574215000265"],"URL":"https:\/\/doi.org\/10.1016\/j.mrrev.2015.04.002","relation":{},"ISSN":["1383-5742"],"issn-type":[{"value":"1383-5742","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Engineered mutations in fibrillin-1 leading to Marfan syndrome act at the protein, cellular and organismal levels","name":"articletitle","label":"Article Title"},{"value":"Mutation Research\/Reviews in Mutation Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mrrev.2015.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}